Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07466121

Comparison of Two Sitting Durations During Saddle Anesthesia on Discharge Readiness in Perianal Surgery

Comparison of Two Sitting Durations During Saddle Anesthesia on Discharge Readiness in Perianal Surgery: A Randomized Controlled Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
62 (estimated)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
21 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Most minor perianal surgeries are performed as day-case procedures requiring rapid recovery and effective symptom control. Saddle block anesthesia (SBA) provides reliable perineal anesthesia with minimal hemodynamic and motor effects, promoting faster recovery than general anesthesia. However, the duration of sitting after intrathecal injection influences anesthetic spread, and the optimal sitting time to balance adequate anesthesia with early discharge remains unclear.

Detailed description

Spinal anesthesia will be administered in the sitting position at the L4-5 interspinous space using 7.5 mg of 0.5% hyperbaric bupivacaine. Hemodynamic data (heart rate and blood pressure) will be recorded at baseline, then at 2 min interval after SBA until the end of surgery. Postoperative pain will be assessed using the numeric rating scale at the post anesthesia care unit (PACU) and before discharge. If the numeric rating scale (NRS) \> 3 or at any time if demanded by the patient, 15 mg of IV ketorolac will be given if persisted titrated doses of nalbuphine will be given In case of postoperative nausea and vomiting, 4 mg of IV ondansetron will be given.

Conditions

Interventions

TypeNameDescription
OTHER5-min sitting duration after SBAPatients will remain seated for 5 min after local anesthetic injection
OTHER8-min sitting duration after SBAPatients will remain seated for 8 min after local anesthetic injection

Timeline

Start date
2026-03-15
Primary completion
2026-07-01
Completion
2026-07-01
First posted
2026-03-12
Last updated
2026-03-17

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07466121. Inclusion in this directory is not an endorsement.